News

Regulatory affairsRegulatory Round-up - May 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Cell Therapy Catapult CEO appointed to Board of UK BioIndustry AssociationCell Therapy Catapult CEO appointed to Board of UK BioIndustry AssociationBioMedical Catalyst grant of £2m for University of Edinburgh liver disease therapyBioMedical Catalyst grant of £2m for University of Edinburgh liver disease therapyRecognition in today’s Hauser review of progress made by Catapult centresRecognition in today’s Hauser review of progress made by Catapult centresCell Therapy Catapult working with Tokyo Electron on Smart Cell Processing TechnologiesCell Therapy Catapult working with Tokyo Electron on Smart Cell Processing TechnologiesPublication of Cell Therapy Catapult’s First ReviewPublication of Cell Therapy Catapult’s First ReviewDesign & Engineering Consultant for new Cell Therapy Manufacturing Centre appointedDesign & Engineering Consultant for new Cell Therapy Manufacturing Centre appointedCBRE appointed as search agent for Cell Therapy Manufacturing Centre siteCBRE appointed as search agent for Cell Therapy Manufacturing Centre siteBusiness Secretary Vince Cable opens Cell Therapy Catapult’s state-of-the-art facilitiesBusiness Secretary Vince Cable opens Cell Therapy Catapult’s state-of-the-art facilitiesUCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapyUCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapyCell Therapy Catapult supports Smith & Nephew on innovative wound care productCell Therapy Catapult supports Smith & Nephew on innovative wound care productCell and Gene Therapy Catapult approach to GMP Manufacturing in the UKCell and Gene Therapy Catapult approach to GMP Manufacturing in the UKUK GMP manufacturing survey shows strong network of early-stage facilitiesUK GMP manufacturing survey shows strong network of early-stage facilities